Myiasis in a Dog Shelter in Greece: Epidemiological and Clinical Features and Therapeutic Considerations
World Small Animal Veterinary Association World Congress Proceedings, 2015
D.C. Orfanou; E. Papadopoulos; P.J. Cripps; L.V. Athanasiou; G. Fthenakis
University of Thessaly, Veterinary Faculty, Karditsa, Greece


Few cases of myiasis are described in domestic carnivores.


Objective of the presentation is to describe myiasis in a cohort of 163 dogs in an animal shelter, monitored over 3.5 years (4 fly activity seasons).


Seven dogs were presented with myiasis; two dogs were presented twice. Overall incidence rate (IR) of myiasis was 5.8 cases per 103 animal-months at risk, or else 0.0058 case per animal-month at risk. Six cases occurred between May to July and three between August to October, giving IRs of 7.7 per 103 animal-months and 3.9 per 103 animal-months, respectively (p = 0.35). Five cases occurred in males and four in females, giving IRs of 7.8 per 103 animal months and 4.3 per 103 animal-months, respectively, (p = 0.41). Three cases were diagnosed as cutaneous myiasis in the thigh, 2 cases as myiasis in the ear canal, 2 in the prepuce, 1 in the toes and 1 case in the vagina. Median time from entrance into the shelter to infestation was 5 months. Wohlfahrtia magnifica larvae were identified. Signs characteristic of local inflammation, in the affected area of the body, were recorded. Treatment included removal of larvae, cleansing, administration of moxidectin and an antimicrobial agent. Recovery took 1.5 months, bar in preputial infestations which required 2.5 months.


The paper presents some information regarding canine myiasis.


Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

G. Fthenakis
University of Thessaly
Veterinary Faculty
Karditsa, Greece

MAIN : Infectious & Emerging Diseases : Myiasis in a Dog Shelter in Greece
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.


777 W. Covell Blvd., Davis, CA 95616


  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357